A phase II study of nab-paclitaxel and gemcitabine in Korean patients with metastatic pancreatic cancer

被引：0
|
作者：
Lee, S. J. [1 ]
Oh, D-Y. [2 ]
Kang, J-H. [3 ]
Choi, H. J. [4 ]
Lee, M. A. [5 ]
Oh, S. Y. [6 ]
Kim, S-T. [7 ]
Park, Y. S. [8 ]
Ryu, B-Y. [9 ]
Park, J. O. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
[3] Gyeongsang Natl Univ, Sch Med, Internal Med, Jinju, Jinju, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Internal Med, Seoul, South Korea
[5] Catholic Univ, Seoul St Marys Hosp, Internal Med, Seoul, South Korea
[6] Dong A Univ, Coll Med, Internal Med, Busan, South Korea
[7] Samsung Med Ctr, Med, Seoul, South Korea
[8] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Hematol Oncol, Seoul, South Korea
[9] Univ Ulsan, Coll Med, Asan Med Ctr, Internal Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
727P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [3] A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.
    Shan, Yan-Shen
    Li, Chung-Pin
    Khan, Gazala
    Lee, Woo Jin
    Choi, Hye Jin
    Chang, Heung-Moon
    Lee, Moon Hee
    Wallmark, John M.
    Chen, Pei-Ni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 648 - 648
  • [4] Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer
    Perez, Kimberly
    Chiarella, Anna M.
    Cleary, James M.
    Horick, Nora
    Weekes, Colin
    Abrams, Thomas
    Blaszkowsky, Lawrence
    Enzinger, Peter
    Giannakis, Marios
    Goyal, Lipika
    Meyerhardt, Jeffrey A.
    Rubinson, Douglas
    Yurgelun, Matthew B.
    Goessling, Wolfram
    Giantonio, Bruce J.
    Brais, Lauren
    Germon, Victoria
    Stonely, Danielle
    Raghavan, Srivatsan
    Bakir, Basil
    Das, Koushik
    Pitarresi, Jason R.
    Aguirre, Andrew J.
    Needle, Michael
    Rustgi, Anil K.
    Wolpin, Brian M.
    [J]. ONCOLOGIST, 2023, 28 (05): : 425 - 432
  • [5] Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Blaydorn, Lisa
    Beck, Julia
    Bornemann-Kolatzki, Kirsten
    Urnovitz, Howard
    Schutz, Ekkhard
    Khemka, Vivek
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 96 - 102
  • [6] Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Glen J. Weiss
    Lisa Blaydorn
    Julia Beck
    Kirsten Bornemann-Kolatzki
    Howard Urnovitz
    Ekkhard Schütz
    Vivek Khemka
    [J]. Investigational New Drugs, 2018, 36 : 96 - 102
  • [7] Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen
    Pleunis-van Empel, Marjolein C. H.
    Richel, Dick J.
    Legdeur, Marie C.
    Nederveen, Aart J.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    [J]. CANCERS, 2021, 13 (19)
  • [8] Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
    Pijnappel, E. N.
    Klaassen, R.
    van der Lee, K. S.
    Pleunis-van Empel, M.
    Richel, D.
    Legdeur, M.
    Nederveen, A.
    van Laarhoven, H. W. M.
    Wilmink, H. W.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [9] Phase II study of induction therapy with gemcitabine and nab-paclitaxel followed by consolidation with mFOLFIRINOX in patients with metastatic pancreatic cancer
    Ramanathan, Ramesh K.
    Lee, Peter
    Seng, John E.
    Anthony, Stephen Patrick
    Rosen, Peter J.
    Mena, Raul R.
    Picozzi, Vincent J.
    Sachdev, Jasgit C.
    Larson, Tim
    Korn, Ronald
    Jameson, Gayle S.
    Stoll, Amy C.
    Von Hoff, Daniel D.
    Leach, Joseph W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [10] Phase II study of induction therapy with gemcitabine and nab-paclitaxel followed by consolidation with mFOLFIRINOX in patients with metastatic pancreatic cancer
    Ramanathan, Ramesh K.
    Lee, Peter
    Leach, Joseph W.
    Anthony, Stephen Patrick
    Weiss, Glen J.
    Rosen, Peter J.
    Picozzi, Vincent J.
    Sachdev, Jasgit C.
    Larson, Tim
    Korn, Ronald
    Hu, Chengcheng
    Jameson, Gayle S.
    Stoll, Amy C.
    Von Hoff, Daniel D.
    Seng, John E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345